Nephrology unit in Mysuru to get permanent hospital infrastructure
With the govt's approval, the building will soon be constructed on a five-acre plot on the PKTB hospital campus on KRS Road in the city. The establishment of this centre will help 69,000 kidney patients avail dialysis, facilitate kidney transplants, and address other health disorders.
The unit on the KR Hospital premises was the second state-run, full-fledged nephrology unit set up by the govt, after Victoria Hospital in Bengaluru, for the benefit of kidney patients from Mysuru, Mandya, Chamarajanagar, Madikeri, and other adjoining districts.
The aim is to reduce pressure on the nephrology unit of Victoria Hospital in Bengaluru and to provide dialysis and other treatments to patients suffering from kidney-related ailments from Mysuru and adjoining districts.
Since the establishment of this unit on KR Hospital premises in Sept 18, 2018, it provided treatment to 69,000 patients suffering from kidney-related problems after admitting them as inpatients.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Find out: this is how you clean your yoga mat!
Kingdom Of Men
Undo
Additionally, 7,078 individuals were treated as outpatients. About 94,000 dialysis processes were conducted for patients at the unit.
As chief minister Siddaramaiah is keen on establishing a permanent building for the unit, he sanctioned Rs 117.7 crore after making necessary budget announcements in 2025-26. The process of constructing permanent buildings for INU has gained momentum on the PKTB hospital premises adjacent to the Jayadeva Institute of Cardiovascular Sciences and Research Institute in Kumbara Koppal on KRS Road in the city.
Speaking to TOI, dean and director of Mysuru Medical College and Research Institute (MMCRI), Dr KH Daskshayini, said MMCRI has already provided five acres for the establishment of this unit on the PKTB premises.
"As the funds were released after necessary administrative and financial approval, the foundation stone was unveiled by the CM at the recently held Sadhana Samavesha at Maharaja's College grounds in Mysuru.
The initial stage of construction work for this building has been expedited by the engineering section of the state health and family welfare department," she said.
This 100-bed hospital will have 50 beds exclusively to provide dialysis treatment for kidney patients at different timings, 20 ICU beds, four modular surgical treatment blocks, a digital library, parking facilities, restrooms for patients, and several other facilities, she said.
Dr JB Narendra, chief of the INU Mysuru unit, said the establishment of this facility will significantly benefit patients in Mysuru and surrounding areas who require dialysis or are dealing with kidney-related issues. With the number of such patients steadily increasing, the new unit will play a vital role in delivering effective and timely treatment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Larvae found every 5 of 100 homes: Kalka, Amravati in Panchkula among dengue hotspots
Panchkula: The health department has marked Kalka Urban, Tibbi Mohalla, Khera Sitaram, Surajpur, Amravati, and nearby villages as high-risk areas for dengue. During door-to-door inspections in June and July, officials found mosquito larvae in more than 5 out of every 100 houses in these areas. Tired of too many ads? go ad free now "It means the risk of dengue is very high here. Since the virus is not in the environment right now, the dengue cases are very low. But the house index for larvae density of more than 5 points to a potential threat at these spots in Aug. If corrective measures are not taken, high number of cases could be reported these spots," a health department official told TOI. As per the data, different teams for door-to-door inspection visited about 2 lakh houses in June and July. In June, 3,600 of these houses were reported to have larvae, while from July 1 to 15, larvae were found in 1,400 more houses. About 1,500 houses were served notices, several others were found locked. "If the hosues do not remove the larvae in the next visit, they will be challaned. The challan amount ranges between Rs 200 and Rs 2,000 depending upon the amount of larvae and frequency of the violation," said an inspection team officer. The teams found larvae in stagnant water under containers of flower pots, uncleaned outdoor coolers, tyres lying in the open, waste material on terraces, and in areas where water is stored in open containers for many days due to scarcity of water. "As the monsoon season progresses, the chances of cases going up will be more. We have requested the Panchkula municipal corporation to start fogging in the district, and in rural areas, the request has been made to the concerned district development and panchayat officer," said a health department official. Tired of too many ads? go ad free now An official said the cases reported so far in 2025 are not of fresh infection as it is yet to spread this year. "The cases were found through the Dengue IgM test, which detects previous infection, while the NS1 test is done to detect fresh infection." BOX: STING TALE Year | Cases | Deaths 2021 | 906 | 1 2022 | 2,022 | 5 2023 | 689 | 2 2024 | 1,324 | 6 2025 | 11* | _ * Of these 11 cases till July, 6 cases were reported in June and 1 in July so far MSID:: 122956538 413 |
Time of India
an hour ago
- Time of India
Punjab rolls out drug prevention curriculum for Classes IX to XII from Aug 1
Chandigarh: The Punjab govt is all set to roll out a drug prevention curriculum for students of Classes IX to XII in all govt schools as part of the third phase of the ongoing "Yudh Nashian De Virudh" campaign, education minister Harjot Singh Bains announced on Monday. Bains said that AAP national convener Arvind Kejriwal and Punjab chief minister Bhagwant Mann will jointly launch the statewide curriculum on Aug 1 at Arniwala in Fazilka district. Sharing details of the initiative, Bains said the pioneering curriculum was developed by J-PAL South Asia, an organisation led by Nobel Laureate Prof Abhijit Banerjee. The programme will target approximately eight lakh students in Classes IX to XII, focusing on prevention-oriented skills to help them resist substance abuse. The curriculum will consist of 35-minute sessions, held every fortnight over 27 weeks, and will use a mix of engaging tools—documentaries, quizzes, posters, and interactive activities. The sessions will cover key areas such as myth-busting, refusal strategies, and resisting peer pressure, equipping students with the knowledge to make informed, healthy choices. The initiative will span 3,658 govt schools and involve more than 6,500 trained teachers, Bains said, underlining its wide reach and potential impact on Punjab's education and public health landscape. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo He emphasised that the programme is evidence-based, developed in consultation with leading behavioural scientists, and evaluated through randomised control trials in 78 govt schools in Amritsar and Tarn Taran during 2024–25. These trials covered 9,600 students and were assessed by J-PAL South Asia. He held that the results were promising: awareness of the high addiction risk from even a single use of 'chitta' increased from 69% in the control group to 90% among students who underwent the program. Moreover, the belief that addiction can be overcome by willpower alone dropped from 50% to 20%, indicating success in debunking harmful myths related to substance abuse.
Time of India
2 hours ago
- Time of India
Wadia doc helps 40 kids with genetic disease get 1cr/yr US drug free for life
Mumbai: Early Monday morning, 14-year-old Bhavin Khare and his mother, Tanuja, set off from Thane's Murbad for Wadia Hospital, Parel, around 100km away, with a sense of anticipation. They had to collect a US drug—estimated to cost over Rs 1 crore for a year's supply—that would help him control the debilitating symptoms of cystic fibrosis, a genetic disease he suffers from. "Bhavin has been struggling all his life. He manages to go to school only 50% of the days due to repeated cough and chest infections," Tanuja said, hoping the new drug would let him lead a "normal life". He is one of five children with cystic fibrosis who received a three-month supply of Trikafta, manufactured by US-based Vertex Pharmaceuticals, at the hospital Monday. Thirty-five others are scheduled to get it in the coming days. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai "We have signed an MoU with the company which, on compassionate grounds, will provide a lifelong supply of Trikafta to 40 patients," said pulmonology department head Dr Parmarth Chandane, who communicated with the US company for almost a year. Due to patent laws, the drug isn't available in India and can only be imported. Affected children in wealthy nations have had access to the drug for almost eight years, and parents' groups in Karnataka, South Africa and Brazil have moved local courts seeking some mechanism like compulsory licensing to ensure their children get access to the drug, too. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Libas Purple Days Sale Libas Undo "The active ingredients for the three-drug combination (Trikafta—elexacaftor/tezacaftor/ivacaftor) that is now being called a miracle, are made in India, but our children don't have access to the finished product," said a doctor who didn't want to be identified. The Wadia Hospital distribution is the beginning of an alternative access for Indian patients. "The drug has shown promise, with certain research reports claiming patients will be able to enjoy a normal lifespan of 80 years as against the 15-20 years one normally associates with the disease," said Dr Chandane, who communicated with the US company for almost a year, seeking access for the 80 patients registered at Wadia Hospital. The company, however, said it would only provide drugs for patients over six years of age, resulting in only 40 qualifying for the free-for-life supply. Each of the affected children has to take three drugs—two in the morning and one in the evening—daily to prevent the buildup of thick, sticky mucus that usually clogs organs such as the lungs, pancreas and intestines, which could further lead to malnutrition, poor growth, frequent respiratory infections, as well as chronic lung disease. It's learnt that Vertex Pharmaceuticals will provide lifelong supply of the drug to patients registered at CMC Vellore in Tamil Nadu, too. "We are also in talks with the company for our patients," said paediatrician Dr Indu Khosla from SRCC Hospital, Haji Ali. "By offering such costly and essential medication free of charge, we're removing financial barriers for families. These children are getting a chance to breathe easier, grow healthy and live longer," said Dr Minnie Bodhanwala, CEO of Bai Jerbai Wadia Hospital for Children.
